These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10979060)

  • 1. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
    Reicin A; White R; Weinstein SF; Finn AF; Nguyen H; Peszek I; Geissler L; Seidenberg BC
    Arch Intern Med; 2000 Sep; 160(16):2481-8. PubMed ID: 10979060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S; Liu N; Dass SB; Reiss TF
    J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
    Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
    Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
    Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children.
    Peroni DG; Piacentini GL; Pietrobelli A; Loiacono A; De Gasperi W; Sabbion A; Micciolo R; Boner AL
    Eur Respir J; 2002 Jul; 20(1):104-7. PubMed ID: 12166555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
    Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
    Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
    J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients.
    Tohda Y; Fujimura M; Taniguchi H; Takagi K; Igarashi T; Yasuhara H; Takahashi K; Nakajima S
    Clin Exp Allergy; 2002 Aug; 32(8):1180-6. PubMed ID: 12190656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
    Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
    J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.
    Reiss TF; Altman LC; Chervinsky P; Bewtra A; Stricker WE; Noonan GP; Kundu S; Zhang J
    J Allergy Clin Immunol; 1996 Sep; 98(3):528-34. PubMed ID: 8828530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.
    Noonan MJ; Chervinsky P; Brandon M; Zhang J; Kundu S; McBurney J; Reiss TF
    Eur Respir J; 1998 Jun; 11(6):1232-9. PubMed ID: 9657560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
    Lu S; Malice MP; Dass SB; Reiss TF
    J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability.
    Zhang J; Yu C; Noonan G; Reiss TF
    Clin Ther; 2002 Apr; 24(4):574-82. PubMed ID: 12017402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
    Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
    Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R; deTineo M; Maleckar B; Naclerio RM; Baroody FM
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.
    Knorr B; Matz J; Bernstein JA; Nguyen H; Seidenberg BC; Reiss TF; Becker A
    JAMA; 1998 Apr; 279(15):1181-6. PubMed ID: 9555757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.